Practical aspects of biological throught levels and antidrug antibodies in rheumatoid arthritis and spondyloarthritis José Rosas; María Martín-López; Teresa Otón; Alejandro Balsa; Jaime Calvo-Alén; Raimon Sanmartí; Jesús Tornero; Loreto Carmona;

Clinical utility of serum concentrations of adalimumab as predictor of treatment adherence Marina Sáez Belló; Pilar Llopis Salvia; Juan José Alegre Sancho; José María Paredes Arquiola; M. del Carmen Asencio Muñoz; Mónica Climente Martí;

Adalimumab treatment of resistant chondrocalcinosis Fatih Tastekin; Kenan Aksu;